Latest | Instant Finance & Market News_第9页 | NewTimeSpace

iShares Asia ex-JP(03010.HK) +2.18%, BOK flags AI capex slowdown risk ] As of 11:29 HKT, Oct 28, 2026, iShares Asia ex-JP(03010.HK) rose 2.18% to HK$84.420; tracking MSCI Asia ex Japan, it holds HK$30.78bn, lot 100.

11:35

iShares Asia ex-Japan 03010.HK ETF Intraday Move

CSOP Gold 2x(07299.HK) +2.45%, Fed rate decision due early Thursday ] As of 11:14 HKT, Oct 28, 2026, CSOP Gold 2x(07299.HK) rose 2.45% to HK$20.060; tracking gold futures at 2x daily leverage, assets HK$1.43bn, lot 100.

11:20

CSOP Gold Futures Daily (2x) Leveraged Product 07299.HK ETF Intraday Move

CSOP KOSPI(03121.HK) +6.17%, SK hynix Q3 operating profit up over 6x ] As of 10:49 HKT, Oct 28, 2026, CSOP KOSPI(03121.HK) rose 6.17% to HK$5.855 on HK$5.37m turnover; tracking KOSPI 200, it holds HK$566m assets, lot 100.

10:57

CSOP KOSPI 200 ETF 03121.HK ETF Intraday Move

Southbound Funds Add Internet Platform Exposure; Csop Hang Seng Tech Index Etf (03033.HK) Rises 1.18% Intraday ] At 9:58 on Oct 28, 2026, Csop Hang Seng Tech Index Etf (03033.HK) rose 1.18% to HK$3.766, turnover HK$1.38 billion, AUM HK$56.5 billion, NAV HK$3.7255.

10:16

ETF CSOP Hang Seng Tech Index ETF 03033.HK

Two Hepatitis B Drugs Granted Breakthrough Therapy Designation; Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) Rises 2.70% Intraday ] At 9:55 on Oct 28, 2026, Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) rose 2.70% to HK$14.450, turnover HK$41.29 million, AUM HK$3.12 billion.

10:00

NewTimeSpace Chinaamc Hang Seng Hong Kong Biotech Index ETF 03069.HK

SK Hynix Q3 Operating Profit Jumps 632%; Csop Ftse Hk-Korea Tech+ Index Etf (03431.HK) Rises 3.25% Intraday ] At 9:53 on Oct 28, 2026, Csop Ftse Hk-Korea Tech+ Index Etf (03431.HK) rose 3.25% to HK$8.895, turnover HK$6.03 million, AUM HK$987.73 million, NAV HK$8.6643.

09:55

ETF Csop Ftse Hk-Korea Tech+ Index ETF 03431.HK

ETERNITY INV (00764.HK): Shares Suspended from 9 am Today ] On 28 Oct 2026, an HKEX notice said trading in ETERNITY INV's (00764.HK) shares was suspended from 9 am that day, with no reason or resumption time given.

08:57

NewTimeSpace ETERNITY INV 00764.HK

JIANGSU EXPRESSWAY (00177.HK): EGM Approves Sunan Expressway Acquisition and Interim Dividend ] On 28 Oct 2026, JIANGSU EXPRESSWAY (00177.HK) said its EGM approved the Sunan Expressway acquisition with 99.97% support and a RMB0.25 interim dividend.

08:22

NewTimeSpace JIANGSU EXPRESSWAY 00177.HK

IRC (01029.HK): Two-for-One Rights Issue to Raise Up to HK$301.9m, Backed by Controlling Shareholder ] On 27 Oct 2026, IRC (01029.HK) proposed a two-for-one rights issue at HK$0.315 to raise up to HK$301.9m, underwritten by its 73.95% shareholder in a connected transaction.

08:20

NewTimeSpace IRC 01029.HK

MEITUAN-W (03690.HK): Issues RMB8bn Senior Notes at 2.50% and 3.10% ] On 28 Oct 2026, MEITUAN-W (03690.HK) priced RMB4.5bn 2.50% 2031 notes and RMB3.5bn 3.10% 2036 notes at par, raising RMB8bn mainly to refinance offshore debt.

08:08

NewTimeSpace MEITUAN-W 03690.HK

SANDS CHINA (01928.HK): US$1bn Notes Priced at 6.400% for 2032 and 6.700% for 2033 ] On 28 Oct 2026, SANDS CHINA (01928.HK) priced US$700m 6.400% 2032 notes and US$300m 6.700% 2033 notes, raising about US$989m net to redeem its 2027 notes.

07:39

NewTimeSpace SANDS CHINA 01928.HK

NEXCHIP (02249.HK): Chairman Proposes A- and H-Share Buy-backs of Up to RMB800m and HK$600m ] On 27 Oct 2026, NEXCHIP (02249.HK) said chairman Cai Guozhi proposed buying back RMB500-800m of A shares and HK$300-600m of H shares, subject to approvals.

07:34

NewTimeSpace Nexchip 02249.HK

ASMPT (00522.HK): Q3 Bookings Hit Record; Revenue Up 48.7% to HK$5.25bn ] On 27 Oct 2026, ASMPT (00522.HK) posted record Q3 bookings of HK$8.45bn, up 137.9% YoY, and revenue of HK$5.25bn, up 48.7%, with Q4 guidance of US$670-730m.

07:30

NewTimeSpace ASMPT 00522.HK

LUFAX (06623.HK): Q3 Revenue RMB6.18bn, Net Loss RMB1.49bn ] On 28 Oct 2026, LUFAX (06623.HK) posted Q3 revenue of RMB6.18bn, down 4.6%, and a net loss of RMB1.49bn, as credit impairment and tax charges rose.

07:26

NewTimeSpace LUFAX 06623.HK

51WORLD (06651.HK): Li Yi Extends Lock-up Commitment to End-2030 ] On 28 Oct 2026, 51WORLD (06651.HK) said chairman and CEO Li Yi extended the lock-up on his 19.70% H-share stake from December 2026 to 30 December 2030.

07:23

NewTimeSpace 51WORLD 06651.HK

BRAINAURORA-B (06681.HK): Depression Cognitive Assessment Software Wins Class II Device Registration ] On 27 Oct 2026, BRAINAURORA-B (06681.HK) won Class II device registration for cognitive assessment software for depression patients.

07:22

NewTimeSpace BRAINAURORA-B 06681.HK

C FIN INT INV (00721.HK): Proposes Issue and Buy-back Mandates; AGM on 27 November ] On 28 Oct 2026, C FIN INT INV (00721.HK) proposed 20% issue and 10% buy-back mandates for its 27 Nov AGM, plus director re-election and auditor re-appointment.

07:12

NewTimeSpace C FIN INT INV 00721.HK

IMMUNOTECH-B (06978.HK): To Place Up to 123.5m New Shares, Raising at Least HK$36.1m ] On 28 Oct 2026, IMMUNOTECH-B (06978.HK) agreed to place up to 123.5m new shares at a minimum HK$0.300 each, a 13.04% discount, to raise at least HK$36.1m net.

07:11

NewTimeSpace IMMUNOTECH-B 06978.HK

FS.COM (03355.HK): trustee buys 370,000 H shares under share award scheme at average HK$37.491 ] FS.COM (03355.HK) said the trustee bought 370,000 H shares under its H-share award scheme at an average of HK$37.491, for a total of about HK$13.87 million.

22:17

FS.COM 03355.HK Share Award Scheme

OCUMENSION-B (01477.HK): fluocinolone acetonide intravitreal implant cleared by NMPA for mainland China production ] OCUMENSION-B (01477.HK) said the NMPA approved mainland China production of its fluocinolone acetonide intravitreal implant, adding a domestic supply source.

22:15

OCUMENSION-B 01477.HK Drug Approval

Scan QR Code

Download App